MDR-TB in Eastern Europe in the era of the TB elimination action framework.
Department of Tuberculosis and Clinical Immunology National Pirogov Memorial Medical University of Vinnytsia Vinnytsia, Ukraine.
Andrii
A
Dudnyk
Department of Phthysiology and Pulmonology Kharkiv National Medical University Kharkiv, Ukraine.
Dmytro
D
Butov
Phthisiopneumology Institute Chisinau, Republic of Moldova; State University of Medicine and Pharmacy 'Nicolae Testemitanu' Chisinau, Republic of Moldova.
Valeriu
V
Crudu
State University of Medicine and Pharmacy 'Nicolae Testemitanu' Chisinau, Republic of Moldova; Division of Clinical Infectious Diseases Research Center Borstel, Germany; German Center for Infection Research, Clinical Tuberculosis Center Borstel, germany; International Health / Infectious Diseases, University of Lübeck Lübeck Germany; Department of Medicine Karolinska Institute Stockholm, Sweden; Department of Internal Medicine University of Namibia School of Medicine Windhoek, Namibia.
Christoph
C
Lange
State University of Medicine and Pharmacy 'Nicolae Testemitanu' Chisinau, Republic of Moldova.
Dumitru
D
Chesov
D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D024901:Drug Resistance, Multiple, Bacterial; D006297:Health Services Accessibility; D054625:Healthcare Disparities; D006801:Humans; D008966:Moldova / Q000453:epidemiology; D011379:Prognosis; D012307:Risk Factors; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D014455:Ukraine / Q000453:epidemiology
D000995:Antitubercular Agents